A genome-wide association study implicates<i>NR2F2</i>in lymphangioleiomyomatosis pathogenesis
Wonji Kim(Brigham and Women's Hospital), David J. Kwiatkowski(Brigham and Women's Hospital), Edwin K. Silverman(Brigham and Women's Hospital), Chin‐Lee Wu(Massachusetts General Hospital), Joel Moss(National Heart Lung and Blood Institute), Magdalena E. Tyburczy(Instytut Biologii Doświadczalnej im. Marcelego Nenckiego), Havi Carel(University of Bristol), Elizabeth P. Henske(Brigham and Women's Hospital), Miguel Ángel Pujana(Bellvitge University Hospital), Sungho Won(Seoul National University), Krinio Giannikou(University of California San Diego), Elżbieta Radzikowska(Masih Daneshvari Hospital), Sanghun Lee(Dankook University), Antonio Román(Centro de Investigación Biomédica en Red), John R. Dreier(Brigham and Women's Hospital), Shulin Wu(Massachusetts General Hospital), Gary M. Hunninghake(Hubei University of Science and Technology)
Cited by 22
Related Papers
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2010|986